16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interventions to prevent hemodynamic instability during renal replacement therapy in critically ill patients: a systematic review

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Hemodynamic instability related to renal replacement therapy (HIRRT) may increase the risk of death and limit renal recovery. Studies in end-stage renal disease populations on maintenance hemodialysis suggest that some renal replacement therapy (RRT)-related interventions (e.g., cool dialysate) may reduce the occurrence of HIRRT, but less is known about interventions to prevent HIRRT in critically ill patients receiving RRT for acute kidney injury (AKI). We sought to evaluate the effectiveness of RRT-related interventions for reducing HIRRT in such patients across RRT modalities.

          Methods

          A systematic review of publications was undertaken using MEDLINE, MEDLINE in Process, EMBASE, and Cochrane’s Central Registry for Randomized Controlled Trials (RCTs). Studies that assessed any intervention’s effect on HIRRT (the primary outcome) in critically ill patients with AKI were included. HIRRT was variably defined according to each study’s definition. Two reviewers independently screened abstracts, identified articles for inclusion, extracted data, and evaluated study quality using validated assessment tools.

          Results

          Five RCTs and four observational studies were included ( n = 9; 623 patients in total). Studies were small, and the quality was mostly low. Interventions included dialysate sodium modeling ( n = 3), ultrafiltration profiling ( n = 2), blood volume ( n = 2) and temperature control ( n = 3), duration of RRT ( n = 1), and slow blood flow rate at initiation ( n = 1). Some studies applied more than one strategy simultaneously ( n = 5). Interventions shown to reduce HIRRT from three studies (two RCTs and one observational study) included higher dialysate sodium concentration, lower dialysate temperature, variable ultrafiltration rates, or a combination of strategies. Interventions not found to have an effect included blood volume and temperature control, extended duration of intermittent RRT, and slower blood flow rates during continuous RRT initiation. How HIRRT was defined and its frequency of occurrence varied widely across studies, including those involving the same RRT modality. Pooled analysis was not possible due to study heterogeneity.

          Conclusions

          Small clinical studies suggest that higher dialysate sodium, lower temperature, individualized ultrafiltration rates, or a combination of these strategies may reduce the risk of HIRRT. Overall, for all RRT modalities, there is a paucity of high-quality data regarding interventions to reduce the occurrence of HIRRT in critically ill patients.

          Electronic supplementary material

          The online version of this article (10.1186/s13054-018-1965-5) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Renal recovery after acute kidney injury

          Acute kidney injury (AKI) is a frequent complication of critical illness and carries a significant risk of short- and long-term mortality, chronic kidney disease (CKD) and cardiovascular events. The degree of renal recovery from AKI may substantially affect these long-term endpoints. Therefore maximising recovery of renal function should be the goal of any AKI prevention and treatment strategy. Defining renal recovery is far from straightforward due in part to the limitations of the tests available to assess renal function. Here, we discuss common pitfalls in the evaluation of renal recovery and provide suggestions for improved assessment in the future. We review the epidemiology of renal recovery and of the association between AKI and the development of CKD. Finally, we stress the importance of post-discharge follow-up of AKI patients and make suggestions for its incorporation into clinical practice. Summary key points are that risk factors for non-recovery of AKI are age, CKD, comorbidity, higher severity of AKI and acute disease scores. Second, AKI and CKD are mutually related and seem to have a common denominator. Third, despite its limitations full recovery of AKI may best be defined as the absence of AKI criteria, and partial recovery as a fall in AKI stage. Fourth, after an episode of AKI, serial follow-up measurements of serum creatinine and proteinuria are warranted to diagnose renal impairment and prevent further progression. Measures to promote recovery are similar to those preventing renal harm. Specific interventions promoting repair are still experimental.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.

            Little information is available regarding current practice in continuous renal replacement therapy (CRRT) for the treatment of acute renal failure (ARF) and the possible clinical effect of practice variation. Prospective observational study. A total of 54 intensive care units (ICUs) in 23 countries. A cohort of 1006 ICU patients treated with CRRT for ARF. Collection of demographic, clinical and outcome data. All patients except one were treated with venovenous circuits, most commonly as venovenous hemofiltration (52.8%). Approximately one-third received CRRT without anticoagulation (33.1%). Among patients who received anticoagulation, unfractionated heparin (UFH) was the most common choice (42.9%), followed by sodium citrate (9.9%), nafamostat mesilate (6.1%), and low-molecular-weight heparin (LMWH; 4.4%). Hypotension related to CRRT occurred in 19% of patients and arrhythmias in 4.3%. Bleeding complications occurred in 3.3% of patients. Treatment with LMWH was associated with a higher incidence of bleeding complications (11.4%) compared to UFH (2.3%, p = 0.0083) and citrate (2.0%, p = 0.029). The median dose of CRRT was 20.4 ml/kg/h. Only 11.7% of patients received a dose of > 35 ml/kg/h. Most (85.5%) survivors recovered to dialysis independence at hospital discharge. Hospital mortality was 63.8%. Multivariable analysis showed that no CRRT-related variables (mode, filter material, drug for anticoagulation, and prescribed dose) predicted hospital mortality. This study supports the notion that, worldwide, CRRT practice is quite variable and not aligned with best evidence.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

              Patients with chronic kidney disease (stage 5) who undergo hemodialysis treatment have similarities to heart failure patients in that both populations retain fluid frequently and have excessively high mortality. Volume overload in heart failure is associated with worse outcomes. We hypothesized that in hemodialysis patients, greater interdialytic fluid gain is associated with poor all-cause and cardiovascular survival. We examined 2-year (July 2001 to June 2003) mortality in 34,107 hemodialysis patients across the United States who had an average weight gain of at least 0.5 kg above their end-dialysis dry weight by the time the subsequent hemodialysis treatment started. The 3-month averaged interdialytic weight gain was divided into 8 categories of 0.5-kg increments (up to > or =4.0 kg). Eighty-six percent of patients gained >1.5 kg between 2 dialysis sessions. In unadjusted analyses, higher weight gain was associated with better nutritional status (higher protein intake, serum albumin, and body mass index) and tended to be linked to greater survival. However, after multivariate adjustment for demographics (case mix) and surrogates of malnutrition-inflammation complex, higher weight-gain increments were associated with increased risk of all-cause and cardiovascular death. The hazard ratios (95% confidence intervals) of cardiovascular death for weight gain or =4.0 kg (compared with 1.5 to 2.0 kg as the reference) were 0.67 (0.58 to 0.76) and 1.25 (1.12 to 1.39), respectively. In hemodialysis patients, greater fluid retention between 2 subsequent hemodialysis treatment sessions is associated with higher risk of all-cause and cardiovascular death. The mechanisms by which fluid retention influences cardiovascular survival in hemodialysis may be similar to those in patients with heart failure and warrant further research.
                Bookmark

                Author and article information

                Contributors
                adouvris@toh.ca
                gmalh035@uottawa.ca
                shiremath@toh.ca
                lmcintyre@ohri.ca
                samuel.silver@queensu.ca
                bagshaw@ualberta.ca
                waldr@smh.ca
                cronco@goldnet.it
                lindsey.sikora@uottawa.ca
                catherine.weber@mcgill.ca
                613-798-5555 , edclark@toh.ca
                Journal
                Crit Care
                Critical Care
                BioMed Central (London )
                1364-8535
                1466-609X
                22 February 2018
                22 February 2018
                2018
                : 22
                : 41
                Affiliations
                [1 ]ISNI 0000 0001 2182 2255, GRID grid.28046.38, Department of Medicine, , University of Ottawa, ; Ottawa, ON Canada
                [2 ]ISNI 0000 0001 2182 2255, GRID grid.28046.38, Division of Nephrology, Department of Medicine and Kidney Research Centre, Ottawa Hospital Research Institute, , University of Ottawa, ; Ottawa, ON Canada
                [3 ]ISNI 0000 0000 9606 5108, GRID grid.412687.e, Division of Critical Care, Department of Medicine, , The Ottawa Hospital, ; Ottawa, ON Canada
                [4 ]ISNI 0000 0000 9606 5108, GRID grid.412687.e, Centre for Transfusion Research, Clinical Epidemiology Program, , Ottawa Hospital Research Institute, ; Ottawa, ON Canada
                [5 ]ISNI 0000 0004 1936 8331, GRID grid.410356.5, Division of Nephrology, , Queen’s University, ; Kingston, ON Canada
                [6 ]GRID grid.17089.37, Department of Critical Care Medicine, Faculty of Medicine and Dentistry, , University of Alberta, ; Edmonton, AB Canada
                [7 ]GRID grid.415502.7, Division of Nephrology, , St. Michael’s Hospital, ; Toronto, ON Canada
                [8 ]ISNI 0000 0004 1758 2035, GRID grid.416303.3, International Renal Research Institute and Department of Nephrology, , St. Bortolo Hospital, ; Vicenza, Italy
                [9 ]ISNI 0000 0001 2182 2255, GRID grid.28046.38, Health Sciences Library, , University of Ottawa, ; Ottawa, ON Canada
                [10 ]ISNI 0000 0004 1936 8649, GRID grid.14709.3b, Division of Nephrology, , McGill University, ; Montreal, Quebec Canada
                [11 ]ISNI 0000 0000 9606 5108, GRID grid.412687.e, The Ottawa Hospital – Riverside Campus, ; 1967 Riverside Drive, Ottawa, ON K1H 7W9 Canada
                Author information
                http://orcid.org/0000-0002-6767-1197
                Article
                1965
                10.1186/s13054-018-1965-5
                5822560
                29467008
                4dcef005-072b-462d-9670-2486c574933c
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 28 October 2017
                : 24 January 2018
                Categories
                Research
                Custom metadata
                © The Author(s) 2018

                Emergency medicine & Trauma
                acute kidney injury,renal replacement therapy,intradialytic hypotension,dialysis,hemodynamic instability

                Comments

                Comment on this article